Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Clinical Trials in Salt Lake City, Utah

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy